101 Therapeutics
About:
101 Therapeutics is a clinical stage pharma company curing infectious diseases by targeting the pathology not the the pathogen.
Website: https://101therapeutics.com
Twitter/X: 101therapeutics
Top Investors: Awz Ventures
Description:
101 Therapeutics is a Phase II pharmaceutical company on a mission to cure infectious diseases by targeting the pathology not the the pathogen. After a successful Phase I safety trial, 101 Therapeutics is conducting a Phase II efficacy trials for its targeted COVID-19 therapy.
Total Funding Amount:
$15M
Headquarters Location:
Tel Aviv, Tel Aviv, Israel
Founded Date:
2020-01-01
Contact Email:
info(AT)101therapeutics.com
Founders:
Alec Goldberg, James Goldberg
Number of Employees:
1-10
Last Funding Date:
2022-10-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai